Anticoagulants Use Patterns among Hospitalized Patients with COVID-19 in A Regional Teaching Hospital during the Pandemic
Journal of Internal Medicine of Taiwan
; 33(3):218-226, 2022.
Article
in Chinese
| Scopus | ID: covidwho-2025284
ABSTRACT
Covid-19 is associated with a higher risk of thrombotic complications, and prophylactic dose anticoagulants are recommended for hospitalized nonpregnant patients by international treatment guidelines. Whether the benefit and efficacy of using anticoagulants among Taiwanese patients remains uncertain, we aimed to evaluate the use of anticoagulants and to investigate the risk factors of the patients. 144 patients with confirmed SARSCoV-2 infection were admitted to a regional teaching hospital in Taipei, Taiwan between May, 2021 and July, 2021. We retrospectively collected these patients' data from electronic medical records. Descriptive statistics, independent t-test and Chi-square were applied for patients' characteristics and important factors. Medication use evaluation was performed through SOAP format for every patient by dedicated pharmacists. There were 29% patients receiving anticoagulants, 90% of the use were for Covid-19 thromboprophylaxis. Among these patients, old age, hypertension and diabetes have a high correlation with mortality and the use of anticoagulants. There was no medication related problem that remains unresolved, all patients were completely assessed. © 2022 Society of Internal Medicine of Taiwan. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
Chinese
Journal:
Journal of Internal Medicine of Taiwan
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS